摘要

This report describes the Advisory Committee on Immunization Practices’ recommendation for using nirsevimab for infants and children to prevent severe respiratory syncytial virus disease.

詳細內容

This report describes the Advisory Committee on Immunization Practices’ recommendation for using nirsevimab for infants and children to prevent severe respiratory syncytial virus disease.

關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---

萃取時間: 2026-02-05T15:10:44Z 資料來源: CDC MMWR